Stay updated with breaking news from Frazier Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Get Rating) in a report issued on Thursday. The firm set a “hold” rating on the stock. A number of other analysts also recently issued reports on SNDX. Zacks Investment Research raised Syndax Pharmaceuticals from a “sell” rating to a “hold” rating in a research […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Stock analysts at Wedbush issued their Q1 2022 earnings per share (EPS) estimates for shares of Alpine Immune Sciences in a research note issued to investors on Monday, March 21st. Wedbush analyst R. Driscoll anticipates that the biotechnology company will earn ($0.27) per share for the […]
Wall Street brokerages expect Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) to post ($0.08) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have issued estimates for Alpine Immune Sciences’ earnings. Alpine Immune Sciences posted earnings per share of ($0.45) in the same quarter last year, which would indicate a positive […]
Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Rating) have earned a consensus recommendation of “Buy” from the six analysts that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target […]